Menu
  • Join
  • Login
  • Contact
 

Search abstracts


COMPARATIVE SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: KAO, Chi-Lan (cathay general hospital, pharmacy, China Taiwan)
  • Co-author(s): Chi-Lan Kao: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan
    Tsai-Ling Chiang: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan
    Ting-Ching Wu: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan
    Wan-Tsui Huang: pharmacy, cathay general hospital, taipei, China Taiwan;Pharmacists, Association, taipei, China Taiwan;School of Pharmacy, Taipei Medical University, taipei, China Taiwan
  • Abstract:

    Background

    Safety of different direct oral anticoagulants (DOACs) (dabigatran, rivaroxaban, edoxaban and apixaban) in patients with non-valvular atrial fibrillation (NVAF) has not been evaluated in clinical practice.

    .

    Methods

    This was a retrospective cohort study. We included patients with NVAF who initiated any of DOACs in the Cathay General

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses